| Issue | Title | |
| Vol 23, No 1 (2023): Development of new viral vaccines | Уважаемые коллеги! | Abstract XML (Rus) PDF (Rus) PDF (Rus) PDF (Rus) PDF (Rus) |
| Vol 17, No 2 (2017) | Haemophilus influenzae type b. Incidence rate and preventive vaccination | Abstract PDF (Rus) |
| M. V. Abramtseva, A. P. Tarasov, T. I. Nemirovskaya, V. P. Kovtun, V. A. Volkov, A. A. Movsesyants | ||
| Vol 23, No 3 (2023) | In vitro antiviral activity of a double-stranded RNA sodium salt-based medicinal product against SARS-CoV-2 | Abstract PDF (Rus) |
| G. M. Ignatyev, E. Yu. Shustova, E. A. Rogozhina, P. A. Belyi, K. Ya. Zaslavskaya, V. A. Merkulov | ||
| Vol 21, No 2 (2021) | In vitro methods for rabies virus detection, and evaluation of their use in the production of rabies immunoglobulin | Abstract PDF (Rus) |
| Yu. K. Gavrilova, S. V. Generalov, E. G. Abramova, A. K. Nikiforov | ||
| Vol 24, No 2 (2024) | In vivo evaluation of tropism and biodistribution of synthetic and natural adeno-associated viral vectors by next-generation sequencing | Abstract PDF (Rus) PDF (Rus) |
| D. O. Maksimov, D. A. Naumova, E. A. Astakhova, V. V. Artemev, S. A. Biryukov, I. S. Abramov, A. A. Navoikova, N. V. Rudev, S. G. Feoktistova, O. V. Glazova, O. N. Mityaeva, P. Yu. Volchkov | ||
| Vol 21, No 2 (2021) | 2020 Russian Federation National Award for outstanding achievements in science and technology | Abstract PDF (Rus) |
| article Editorial | ||
| Vol 19, No 3 (2019) | 4th Russian Conference on Medicinal Chemistry with International Participants «MedChem Russia 2019» | Abstract PDF (Rus) |
| article Editorial | ||
| Vol 17, No 2 (2017) | 5th All-Russian scientific-practical conference with international participation «Actual issues of prevention, diagnosis and treatment of tuberculosis in children and adolescents» in conjunction with the meeting of the profile commission of the Ministry of Health of the Russia in the specialty «Phthisiology» with the chief freelance child specialist phthisiatrician | Abstract PDF (Rus) |
| Editorial Article | ||
| Vol 25, No 1 (2025) | A modified single-domain antibody candidate for the treatment of botulism caused by botulinum toxin type A | Abstract PDF (Rus) |
| A. A. Derkaev, E. I. Ryabova, I. B. Esmagambetov, D. V. Shcheblyakov, A. N. Noskov, I. D. Vinogradova, V. V. Prokofiev, D. S. Polyansky, D. Y. Logunov, A. L. Gintsburg | ||
| Vol 24, No 2 (2024) | Adeno-associated virus vector-based gene therapy for hereditary diseases: current problems of application and approaches to solve them | Abstract PDF (Rus) PDF (Rus) |
| T. V. Egorova, A. A. Piskunov, D. A. Poteryaev | ||
| Vol 22, No 4 (2022): Development of biologicals for the prevention, diagnosis, and treatment of COVID-19 | An experience of scaling and intensifying the industrial production of the Gam-COVID-Vac vector adenovirus vaccine in the limiting conditions of the pandemic | Abstract PDF (Rus) |
| A. N. Morozov, I. R. Yakhin, N. V. Stratonova, M. V. Kutskir, D. A. Poteryaev, R. A. Khamitov | ||
| Vol 20, No 1 (2020) | An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare | Abstract PDF (Rus) |
| D. V. Gorenkov, L. M. Khantimirova, V. A. Shevtsov, A. V. Rukavishnikov, V. A. Merkulov, Yu. V. Olefir | ||
| Vol 23, No 1 (2023): Development of new viral vaccines | Analysis of approaches to sterility testing of COVID-19 prevention vaccines | Abstract PDF (Rus) PDF (Rus) PDF (Rus) PDF (Rus) PDF (Rus) |
| S. M. Sukhanova, A. S. Tikhonova, Z. E. Berdnikova | ||
| Vol 18, No 2 (2018) | Analysis of Batch to Batch Consistency of a Locally Produced Influenza Vaccine for the 2017–2018 Influenza Season | Abstract PDF (Rus) |
| P. V. Demidova, K. M. Mefed, D. S. Davydov, K. A. Sarkisyan, A. A. Movsesyants, V. A. Merkulov | ||
| Vol 17, No 2 (2017) | Analysis of biological and genetic stability of tick-borne encephalitis strain 205 used in the production of tick-borne encephalitis vaccines EnceVir and EnceVir Neo for children | Abstract PDF (Rus) |
| M. S. Vorobyeva, G. M. Ignatyev, N. A. Netesova, E. V. Otrashevskaya, N. Kh. Stavitskaya, M. S. Shcherbinina, K. A. Sarkisyan, V. A. Shevtsov, A. V. Rukavishnikov, V. P. Bondarev | ||
| Vol 24, No 4 (2024) | Analysis of current regulatory requirements for the quality of live bacterial vaccines and prospects for the improvement of vaccine quality control methods | Abstract PDF (Rus) |
| T. I. Nemirovskaya, I. V. Kasina, N. V. Aleksandrova, S. A. Alekseeva | ||
| Vol 18, No 1 (2018) | Analysis of Efficacy and Safety of Tick-Borne Encephalitis Vaccines | Abstract PDF (Rus) |
| T. Yu. Kozlova, L. M. Khantimirova, A. V. Rukavishnikov, V. A. Shevtsov | ||
| Vol 19, No 3 (2019) | Analysis of Measles Incidence in Russia and Problems of Measles Prevention at the Elimination Stage | Abstract PDF (Rus) |
| T. N. Yunasova, D. V. Gorenkov, A. V. Rukavishnikov, A. A. Movsesyants, V. A. Merkulov | ||
| Vol 22, No 2 (2022) | Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine | Abstract PDF (Rus) |
| V. P. Trukhin, A. E. Evtushenko, E. L. Salimova, A. D. Konon, M. R. Khaitov, V. A. Merkulov | ||
| Vol 20, No 4 (2020) | Analysis of Promising Approaches to COVID-19 Vaccine Development | Abstract PDF (Rus) |
| G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich | ||
| Vol 17, No 2 (2017) | Analysis of the demand for reference standards used in quality evaluation of biologicals | Abstract PDF (Rus) |
| V. I. Klimov, E. I. Sakanyan, R. A. Volkova, O. V. Fadeykina, A. A. Movsesyants, E. V. Lebedinskaya, A. P. Shestakova | ||
| Vol 16, No 3 (2016) | Andrei Vladimirovich Rukavishnikov (on the 50th anniversary) | Details PDF (Rus) |
| Editorial Article | ||
| Vol 16, No 4 (2016) | Andrey Rudol’fovich Volgin (on the 55th anniversary) | Details PDF (Rus) |
| Editorial Article | ||
| Vol 25, No 2 (2025) | Application of 3Rs principles to assess the quality of DPT vaccine: Advantages and disadvantages | Abstract PDF (Rus) |
| E. I. Komarovskaya, O. V. Proskurina | ||
| Vol 24, No 1 (2024) | Application of alternative identification methods for live tularaemia and brucellosis vaccines | Abstract PDF (Rus) PDF (Rus) |
| I. V. Kasina, S. A. Alekseeva, T. I. Nemirovskaya | ||
| Vol 24, No 2 (2024) | Application of therapeutic nucleic acids and RNA interference to create products for personalised medicine | Abstract PDF (Rus) PDF (Rus) |
| I. P. Shilovskiy, G. B. Pasikhov, V. V. Smirnov, I. A. Kofiadi, M. V. Popova, P. A. Strueva, M. R. Khaitov | ||
| Vol 20, No 4 (2020) | Applied Research Conference “Current Approaches to Evaluation of Medicinal Products” (RegLek 2020) | Abstract PDF (Rus) |
| article Editorial | ||
| Vol 20, No 2 (2020) | Applied Research Conference “Expert Evaluation and Approval of Medicinal Products in the Eurasian Economic Union” (“RegLek EAEU 2020”) | Abstract PDF (Rus) |
| artiсle Editorial | ||
| Vol 18, No 3 (2018) | Approaches to Pharmaceutical Analysis of Modern Peptide and Oligonucleotide Products as Illustrated by a Small Interfering RNA-Based Novel Therapeutic for the Treatment of Bronchial Asthma | Abstract PDF (Rus) |
| L. M. Krasnykh, V. V. Smirnov, G. V. Ramenskaya, G. F. Vasilenko, I. P. Shilovsky, M. R. Haitov | ||
| Vol 21, No 4 (2021) | Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines | Abstract PDF (Rus) |
| L. M. Khantimirova, D. V. Gorenkov, S. G. Guseva, V. A. Merkulov, A. A. Soldatov | ||
| Vol 22, No 4 (2022): Development of biologicals for the prevention, diagnosis, and treatment of COVID-19 | Aspects and issues of marketing authorisation and use of medicinal products for COVID-19 prevention during the pandemic | Abstract PDF (Rus) |
| A. A. Soldatov, D. V. Gorenkov, V. A. Merkulov, V. P. Bondarev | ||
| Vol 20, No 1 (2020) | Aspects of a Methodological Approach to Determination of Interferon Alpha Specific Activity | Abstract PDF (Rus) |
| M. L. Baykova, I. M. Shcherbachenko, L. A. Gayderova, O. B. Ustinnikova, A. A. Movsesyants | ||
| Vol 17, No 1 (2017) | Assessment of biotechnological products specific activity | Abstract PDF (Rus) |
| N. A. Alpatova, L. A. Gayderova, A. K. Yakovlev, E. V. Motuzova, S. L. Lysikova, A. A. Soldatov, Zh. I. Avdeeva | ||
| Vol 21, No 3 (2021) | Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit | Abstract PDF (Rus) |
| D. A. Poteryaev, S. G. Abbasova, P. E. Ignatyeva, O. M. Strizhakova, S. V. Kolesnik, R. A. Khamitov | ||
| No 4 (2015) | Authentification and stability assessment of master-seed and control strains of pathogenic bacteria-causative agents of actual infections | Abstract PDF (Rus) |
| D. S. Davydov, M. P. Rudnik, A. A. Movsesyants, S. M. Chizhonkova, V. A. Parashina, G. M. Tumanova, A. V. Golubeva | ||
| Vol 19, No 1 (2019) | Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA | Abstract PDF (Rus) |
| A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. D. Mosyagin | ||
| Vol 17, No 4 (2017) | Basic approaches to data management for administration of biological collections | Abstract PDF (Rus) |
| D. S. Davydov, K. A. Koshechkin, A. A. Movsesyants | ||
| Vol 18, No 2 (2018) | BCG Tuberculosis Vaccine: Immunological and Clinical Efficacy in Children Born to HIV-Infected Women | Abstract PDF (Rus) |
| N. I. Klevno, V. A. Aksenova | ||
| Vol 20, No 2 (2020) | Bioethical Aspects of Improving the Production of Rabies Immunoglobulin in Russia | Abstract PDF (Rus) |
| S. V. Generalov, E. G. Abramova, Yu. K. Gavrilova | ||
| Vol 19, No 2 (2019) | Biomedical Cell Products or High-Tech Drugs? | Abstract PDF (Rus) |
| V. A. Merkulov, E. V. Melnikova | ||
| Vol 23, No 3-1 (2023): Development and improvement of russian biologicals | Biopharmaceutical properties of polyvalent bacteriophage capsules | Abstract PDF (Rus) |
| A. M. Nikolaeva, N. A. Kovyazina, E. V. Funkner, A. N. Krasilnikova, K. A. Lysko | ||
| No 3 (2015) | Biosimilars - advantages and prospects | Abstract PDF (Rus) |
| A. A. Lidzhiyeva, E. A. Smolyarchuk, E. A. Eltsova | ||
| Vol 16, No 3 (2016) | Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development | Abstract PDF (Rus) |
| A. A. Lidzhieva, E. A. Smolyarchuk, A. E. Kokorina, V. V. Smirnov, E. A. Egorenkov | ||
| No 3 (2015) | Blood preparations of humans and animals in terms of their quality, efficacy and safety | Abstract PDF (Rus) |
| M. V. Supotnitsky, A. A. Elapov, I. V. Borisevich, E. Yu. Kudasheva, V. I. Klimov, E. V. Lebedinskaya, L. V. Korsun, E. V. Gorbunova, V. G. Slobodayn, V. A. Merkulov, Yu. V. Olefir | ||
| Vol 23, No 3 (2023) | Botulinum toxin preparations: areas for improvement and issues of standardisation | Abstract PDF (Rus) |
| M. V. Savkina, M. A. Krivykh, L. V. Sayapina, Yu. I. Obukhov, V. P. Bondarev | ||
| Vol 18, No 2 (2018) | Carbohydrate-Based Adjuvants for Vaccine Production | Abstract PDF (Rus) |
| S. S. Kurashova, T. K. Dzagurova, A. A. Ishmukhametov, M. S. Egorova, M. V. Balovneva, S. E. Sotskova, E. A. Tkachenko | ||
| Vol 17, No 4 (2017) | Cell cultures in replacement therapy | Abstract PDF (Rus) |
| E. M. Petruchuk, N. V. Shalunova, Yu. V. Olefir, I. V. Borisevich, V. V. Perekrest, V. A. Shevtsov, A. V. Rukavishnikov, L. M. Khantimirova | ||
| Vol 24, No 4 (2024) | Cell-based medicinal products: a review of current research | Abstract PDF (Rus) |
| E. V. Galitsyna, E. A. Kulikova, Yu. A. Pavelyev, O. S. Kuznetsova, A. S. Senina, A. B. Gusev | ||
| Vol 17, No 2 (2017) | Certification and potential future use of the reference standard designed for the test system for determination of the fractional (antigenic) composition of human serum products by immunoelectrophoresis | Abstract PDF (Rus) |
| O. G. Kornilova, I. L. Arefyeva, E. S. Konovalova, R. A. Volkova, O. V. Fadeykina, E. Yu. Kudasheva, A. A. Movsesyants | ||
| No 4 (2015) | Certification and shelf-life extension of a new batch of the branch reference standard for live tularemic vaccine's specific activity and immunogenicity | Abstract PDF (Rus) |
| I. V. Kasina, A. A. Goryaev, L. I. Rashchepkin, O. V. Fadeykina, T. I. Nemirovskaya, O. B. Ustinnikova, O. A. Lobovikova, S. A. Alekseeva, R. A. Volkova, A. A. Movsesyants | ||
| 1 - 50 of 405 Items | 1 2 3 4 5 6 7 8 9 > >> | |
Browse Title Index
Popular articles
Vol 24, No 2 (2024)
Vol 24, No 3 (2024)
Vol 24, No 4 (2024)
Vol 25, No 1 (2025)
Vol 25, No 2 (2025)
Keywords
COVID-19
ELISA
SARS-CoV-2
biomedical cell products
clinical trials
gene therapy
identification
immunity
immunogenicity
potency
preventive vaccination
quality control
reference standard
safety
specific activity
vaccination
vaccine
vaccines
validation
whole-cell pertussis vaccine
специфическая активность
Publisher: Scientific Centre for Expert Evaluation of Medicinal Products
